Rit2 loss in dopaminergic neurons drives a Parkinsonian phenotype
Patrick J. KearneyiD, Yuanxi ZhangiD, Yanglan Tan, Elizabeth W. KahunoiD, Tucker L. Conklin, Rita R. FaganiD, Rebecca G. Pavchinskiy, Scott A. Shafer, Zhenyu YueiD, Haley E. MelikianiD
Abstract
Parkinsons disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD DA neurons, potentially linking Rit2 expression loss to a PD patient cohort. However, it is still unknown whether Rit2 loss itself is causative for PD or PD-like symptoms. Here we report that conditional Rit2 silencing in mouse DA neurons drove motor dysfunction that occurred earlier in males than females and was rescued at early stages by either inhibiting the DA transporter (DAT) or with L-DOPA treatment. Motor dysfunction was accompanied by decreased DA release, striatal DA content, phenotypic DAergic markers, DA neurons, and DAergic terminals, with increased pSer129-alpha synuclein and pSer935-LRRK2 expression. These results provide the first evidence that Rit2 loss is causal for SNc cell death and a PD-like phenotype, and reveal key sex-specific differences in the response to Rit2 loss.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival
Jongkyun Kang, Guodong Huang, … Jie Shen·eLifePeer-reviewed·Jun 10, 2024
- Conditional, inducible gene silencing in dopamine neurons reveals a sex-specific role for Rit2 GTPase in acute cocaine response and striatal function
Carolyn G. Sweeney, Patrick J. Kearney, … Haley E. Melikian·NeuropsychopharmacologyPeer-reviewed·Jul 5, 2019
- A pH-eQTL interaction at the RIT2-SYT4 Parkinson's disease risk locus in the substantia nigra
Sejal Patel, Derek Howard, Leon French·Frontiers in Aging NeurosciencePeer-reviewed·Jul 9, 2021
- Sex- and age-dependent control of dopamine function by LRRK2, and rapid reversal of dopamine release deficits in the LRRK2-G2019S knock-in mouse model of Parkinson's Disease.
Christina Gentle, Anusha Kamesh, … Austen J. Milnerwood·bioRxiv·Oct 16, 2026
- Transcriptome responses to reduced dopamine in the Substantia Nigra Pars Compacta reveals a potential protective role for dopamine.
M. Koltun, Karol Cichewicz, … Jay Hirsh·bioRxiv·Sep 9, 2019
- Novel insights in the pathophysiology of α-synuclein dysregulation on D2 receptor activity contributing to the vulnerability of dopamine neurons
Abeer Dagra, Douglas R. Miller, … Habibeh Khoshbouei·bioRxiv·Mar 30, 2021